Skip to main content

Table 2 Evolution of organ failure, vital signs, and laboratory findings during ICU stay according to the use of corticosteroids. Early = in the first 48 h of ICU admission

From: Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study

 

Whole cohort

Never

Early

Delayed

p value

n (%)

882

191 (21.7%)

485 (55.0%)

206 (23.3%)

 

Mechanical ventilation, n (%)

722/882 (81.9%)

139/191 (72.8%) a

395/485 (81.4%)

188/206 (91.3%)

 < 0.001

Vasopressor use, n (%)

639/882 (72.4%)

126/191 (66.0%)

343/485 (70.7%)

170/206 (82.5%) c

 < 0.001

Renal replacement therapy, n (%)

96/867 (11.1%)

14/183 (7.6%)

40/479 (8.3%)

42/205 (20.5%) c

 < 0.001

SOFA maximum

8.6 (3.7)/729

8.2 (3.5)/132

8.2 (3.5)/426

9.7 (4.0)/171 c

 < 0.001

Vital Signs

     

Temperature maximum, ºC

37.9 (1.0)/869

37.9 (1.0)/183

37.7 (1.0)/481 b

38.2 (1.0)/205

 < 0.001

Mean arterial pressure minimum, mmHg

68.8 (13.0)/868

70.7 (13.4)/182

69.1 (13.0)/480

66.4 (12.3)/206 c

0.001

Heart rate maximum, bpm

105.6 (20.9)/868

103.9 (21.7)/182

104.6 (20.9)/480

109.5 (19.9)/206c

0.006

SpO2, minimum, %

78.6 (16.2)/869

80.3 (16.2)/184

79.4 (15.1)/480

75.3 (18.2)/205 c

 < 0.001

Respiratory rate, maximum, bpm

30 (7.0)/859

31 (7.7)/177

30 (6.6)/477

32 (7.2)/205 c

0.005

Respiratory rate, minimum, bpm

17 (4.4)/859

19 (5.0)/177 a

17 (4.4)/477

16 (3.8)/205

 < 0.001

Arterial blood gas

     

PaO2/FiO2 minimum

98.3 (47.9)/833

107.6 (56.9)/167a

96.6 (43.5)/466

94.3 (48.5)/200

0.03

PaCO2 maximum, mmHg

61.8 (19.3)/855

65.0 (21.2)/178

58.9 (18.0)/473 b

66.4 (19.3)/204

 < 0.001

Laboratory findings

     

Ferritin maximum, ng/mL

2305 (2257)/667

1771 (1863)/104a

2314 (2251)/389

2604 (2432)/174

0.003

D-Dimer maximum, ng/mL

5124 (2983)/809

4124 (2823)/158 a

5176 (3008)/452

5799 (2848)/199

 < 0.001

CRP maximum, mg/dL

121 (138)/845

124 (140)/172

111 (128)/472

142 (154)/201 c

0.005

Lymphocytes minimum, mL

0.45 (0.34)/848

0.60 (0.41)/175 a

0.42 (0.31)/471

0.39 (0.29)/202

 < 0.001

CRP/ lymphocyte ratio maximum

273 (447)/843

237 (382)/171

245 (389)/471

368 (590)/201 c

0.004

IL-6 maximum, pg/mL

957 (1787)/314

545 (1142)/22

933 (1803)/218

1148 (1884)/74

0.14

LDH maximum, U/L

648 (382)/828

566 (339)/162 a

659 (394)/467

686 (379)/199

 < 0.001

Leukocytes maximum, 103/mL

15.5 (10.0)/843

13.1 (7.7)/173 a

16.2 (10.5)/467

15.9 (10.3)/203

0.001

Procalcitonin maximum, ng/mL

4.1 (9.9)/756

3.4 (9.5)/143

3.1 (7.3)/434

7.1 (14.2)/179 c

 < 0.001

Platelets maximum, 1000/mm3

387 (153)/852

390 (152)/176

377 (149)/473

405 (161)/203 c

0.03

Bilirubin, maximum, mg/dL

2.3 (3.7)/803

1.8 (2.2)/152 a

2.3 (3.4)/461

2.9 (4.8)/190

0.001

AST maximum, U/L

198 (372)/845

145 (274)/175 a

199 (346)/470

240 (483)/200

 < 0.001

Creatinine maximum, mg/dL

1.8 (1.7)/851

1.8 (1.8)/175

1.7 (1.5)/473

2.2 (1.9)/203 c

0.02

Urea maximum, mg/dL

115 (161)/764

117 (316)/157

106 (69)/423

135 (106)/184 c

 < 0.001

NTProBNP, maximum pg/mL

1996 (4815)/261

2573 (6712)/41

1684 (4693)/152 b

2344 (3590)/68

0.04

Haematocrit minimum, %

38.2 (6.0)/834

37.0 (6.4)/171

38.8 (5.8)/464 b

37.8 (5.7)/199

0.003

Lactate maximum, mmol/L

0.4 (0.8)/692

0.3 (0.5)/142

0.4 (0.7)/392

0.4 (1.2)/158

0.33

  1. Statistically significant results are in italics
  2. aNever significantly different from early and delayed
  3. bearly significantly different from never and delayed
  4. cdelayed significantly different from never and early
  5. SOFA: Sequential Organ Failure Assessment; CRP: C-reactive protein; LDH: lactate dehydrogenase; AST: aspartate Aminotransferase; NTProBNP: N-terminal pro-brain natriuretic peptide